Objective-To assess trends in elective single ET and identify factors associated with a good perinatal outcome.
The elective single ET study population was defined as fresh, nondonor cycles in which a single embryo was transferred and at least one supernumerary embryo was available for cryopreservation. The comparison group consisted of all other fresh, nondonor cycles. These included cycles in which only one embryo was available for transfer (single ET without additional embryos available for cryopreservation), as well as transfers of more than one embryo.
The characteristics assessed included maternal age, race/ethnicity, infertility diagnosis, number of prior pregnancies, number of prior spontaneous abortions, number of prior live births, number of prior ART cycles, year of cycle treatment, insurance mandate status for state of residence, number of oocytes retrieved, use of intracytoplasmic sperm injection (ICSI) (± male factor infertility), use of assisted hatching, use of preimplantation genetic diagnosis (for years 2004 and later), embryo stage at transfer, number of embryos transferred, and number of supernumerary embryos cryopreserved. Because race/ethnicity was unknown or missing in nearly 40% of the study population, an unknown/missing category was included to allow evaluation of these data in multivariable analyses. Also, as patients may have had more than one infertility diagnosis, these diagnoses were not mutually exclusive. To assess potential temporal differences in elective single ET practices, we compared transfers performed in 2005-2010 with those performed in 1999-2004, as the first ASRM/SART guidelines recommending elective single ET were published in September 2004 (14) . With regard to embryo stage at transfer, we chose to restrict our analysis to the two most common days for embryo transfer (day 3 for cleavage stage and day 5 for blastocyst stage), which together represented 82.5% of all transfers.
A "good perinatal outcome" was defined as the live birth of a singleton infant born at term (≥37 completed weeks of gestation) and at a normal birth weight (≥2,500 g) (15) . Gestational age was calculated by subtracting the date of oocyte retrieval from the date of delivery, then adding 14 days to adjust for the theoretical date of the last menstrual period.
We used SAS statistical software version 9.3 (SAS Institute) to conduct all analyses. For all transfers and selected maternal age strata, we calculated the percentage of all ETs meeting elective single ET criteria for each year. We used Mantel-Haenszel statistics to assess trends in the proportion of elective single ET during the study period, and two-tailed χ 2 tests to compare the distribution of maternal and cycle characteristics for the elective single ET group with all other fresh, nondonor transfers during the study period.
To evaluate factors associated with good perinatal outcome among the cycles with elective single ET, we calculated the frequency of good outcomes for each of these maternal and cycle characteristics. Log-binomial models were used to calculate unadjusted and adjusted risk ratios (RR) for the association between maternal and cycle characteristics and a good perinatal outcome after elective single ET. The number of previous pregnancies was not included as a predictor in the adjusted models because it represented the sum of number of previous abortions and number of previous live births, two variables that were already included in the model. Preimplantation genetic diagnosis was also excluded from the models because this information was not ascertained for all study years. We also conducted stratified analyses to examine potential effect modification by maternal age using a variety of different maternal age groupings; no differential effects were noted thus stratified results were not presented. Due to the high proportion of missing or unknown race data, we compared the findings for adjusted models with and without the race variable. Because differences between the two models were nominal, we retained race in the final model.
RESULTS
During the study years 1999-2010, a total of 1,541,825 ART cycles were included in NASS. Of the 1,111,766 cycles using fresh, nondonor oocytes, 886,686 (79.8%) proceeded to transfer at least 1 embryo, and 17,166 (1.9%) met elective single ET criteria.
Until 2004, less than 1% of all transfers in the United States were elective single ET (Fig. 1) . Since that time, there has been an eightfold increase in national elective single ET rates (from 0.72% in 2004 to 5.6% in 2010). In 2010, 9.3% of all transfers in women less than 35 years of age were elective single ET, as were 5.1% of ETs in women aged 35-37 years. Since 1999, each age group has shown a significant positive trend in rates of elective single ET (all P for trend <.001).
With the exception of number of prior pregnancies, the distribution of all characteristics assessed differed significantly between the elective single ET group and all other transfers ( More than one-third of elective single ET resulted in a good perinatal outcome (37.1%, compared with 18.9% of all other transfers during the same period [data not shown]). Approximately 40% of elective single ET in the two youngest age groups (<30 years and 30-34 years) resulted in a good perinatal outcome, whereas 32.5% of elective single ET in the 35-to 37-year-old age group reported the same outcome (Table 2) . Among all other transfers, approximately 22% and 20% of transfers in women <35 and 35-37 years, respectively, resulted in a good perinatal outcome. The findings were similar for women with no prior ART cycles (23% and 21%, respectively) (data not shown). Patients undergoing ART for the first time also had a higher-than-average rate of good outcomes (38.4%). Among cycles where ET occurred on day 5, 39.7% resulted in a good perinatal outcome. Similarly, when five or more supernumerary embryos were available for cryopreservation 41.0% of cycles resulted in a good perinatal outcome.
In the adjusted model, a primary diagnosis of male factor infertility, a treatment start date of 2005 or later, and an ET on day 5 were positively associated with a good perinatal outcome after elective single ET. The following characteristics were found to be negatively associated with a good perinatal outcome: race/ethnicity (specifically, non-Hispanic black, Hispanic, or Asian/Pacific Islander); primary infertility diagnosis of uterine factor; use of ICSI; and use of assisted hatching.
The strongest positive association with good perinatal outcome was for the use of day 5 ET, compared with day 3 ET (adjusted RR 1.33, confidence interval [CI] 1.24-1.43). Conversely, the strongest negative associations were estimated for maternal age of 41 years or older, compared with age less than 30 years (adjusted RR 0.36, CI 0.23-0.57), and nonHispanic black race, compared with non-Hispanic white race (adjusted RR 0.60, CI 0.50-0.72).
Among the predictors with ordinal categories, significant linear trends in the risk ratios were noted for maternal age, number of prior spontaneous abortions, and number of supernumerary embryos cryopreserved.
DISCUSSION
Using national data on cycles of fresh, nondonor ETs, we found that rates of elective single ET increased significantly across all age groups from 1999-2010, with elective single ET comprising 5.6% of ART cycles in 2010. This trend is likely due to continually evolving guidelines from ASRM and SART promoting fewer embryos per transfer, as well as improvements in embryo culture that have facilitated the selection of higher quality embryos for transfer (1, 16) . Although we observed an eightfold increase in elective single ET rates during the study period, the proportion of elective single ET in the United States remains low compared with other developed countries (1) . Although the greatest increases in the present study were observed among patients less than 35 years of age, for whom ET guidelines currently recommend elective single ET, rates of elective single ET among patients aged 35-37 years have increased by an average of 0.7% per year since 2004, and comprised more than 5% of all transfers in this age group in 2010. This trend suggests that clinicians are expanding the current elective single ET guidelines to include a slightly broader patient population, although it is unclear what prognostic criteria are being used to identify good candidates.
Previous studies investigating prognostic criteria for elective single ET evaluated the outcomes of clinical pregnancy or live birth (1, 11, (17) (18) (19) . We chose to focus on having a good perinatal outcome. This measure, a variation of the Birth Emphasizing a Successful Singleton at Term outcome, which was first proposed by Min and colleagues (20) , attempts to redefine "success" after ART as the delivery of a healthy singleton infant. We found that elective single ETs were nearly twice as likely to result in a good perinatal outcome compared with all other fresh, nondonor ETs. This finding adds to the growing body of literature supporting elective single ET as an effective means of avoiding the adverse outcomes commonly associated with ART (15, 21) .
Within the elective single ET group, good perinatal outcomes were most common among women less than 35 years of age or those undergoing their first ART cycle-the women considered to be of "a more favorable prognosis" by ASRM/SART guidelines on number of embryos transferred (22) . However, 32.5% of elective single ET in women aged 35-37 years resulted in a good perinatal outcome (vs. 40.2% in the under-35-years cohort). These findings, like those of Veleva and co-workers (23) suggest that the ET guidelines could potentially be expanded to include the age group 35-37 years as candidates for elective single ET. The increasing rates of elective single ET observed in this age group suggest that clinicians may already be practicing based on anecdotal evidence supporting this conclusion.
In our analysis, the strongest independent predictor of a good perinatal outcome after elective single ET was ET on day 5. This finding builds on a study in which Papanikolaou and co-workers (24) found higher rates of pregnancy and delivery among a group of favorable prognosis patients undergoing transfer of a single blastocyst-stage embryo, compared with those undergoing transfer of a single cleavage-stage embryo. We also found having three or more supernumerary embryos available for cryopreservation is associated with a good outcome. The survival of one or more embryos in culture until day 5, for transfer or cryopreservation, may be an indirect measure of "good embryo quality," which current ET guidelines include as a characteristic associated with a more favorable prognosis (22) .
We found significant racial/ethnic disparities with respect to good perinatal outcomes after elective single ET. Specifically, non-Hispanic black, Hispanic, and Asian/Pacific Islander race/ethnicity were less likely to have a good perinatal outcome after elective single ET. Although these findings are consistent with other analyses of national ART data (25-29), they should be interpreted with caution; in nearly 40% of cycles, data regarding maternal race/ethnicity was missing or unknown. A recent systematic review of national race/ ethnicity reporting for ART suggested that it is not possible to draw definitive conclusions regarding disparities due to lack of universal reporting of this race/ethnicity (30).
Although the diagnosis of male factor infertility has yet to be reported as a prognostic factor for elective single ET, we found it to be a positive predictor of good perinatal outcome. A potential explanation for this finding may be that, among couples where male factor is the only infertility diagnosis, the female is otherwise healthy and therefore more likely to have a good perinatal outcome. Furthermore, we found uterine factor infertility to be inversely associated with good perinatal outcome, which is consistent with previous studies that demonstrated worsened pregnancy outcomes among patients with uterine factor (11, 15) . Interestingly, in a previous analysis of national data, Luke and colleagues (31) suggested that the diagnosis of uterine factor was more common among women undergoing elective single ET; however, our data do not support their conclusion.
Strengths of our study include the use of nationwide surveillance data with nearly universal reporting of ART procedures, which allowed for the analysis of the largest population of elective single ET in the United States to date. Furthermore, the use of multiple years of national data allowed for the first comprehensive analysis of elective single ET trends in the United States. Unlike previous studies evaluating prognostic criteria for elective single ET, we did not restrict our study population to patients with a favorable prognosis. Given the large sample size and increased representativeness of national data, our findings can be applied broadly by clinicians to all patients considering ART.
Our findings are subject to several limitations. As indicated in the SART reporting guidelines, elective single ET is generally defined as "an embryo transfer in which more than one high-quality embryo exists but it was decided to transfer only one embryo."
Because NASS does not collect information on embryo morphology, our definition of elective single ET did not include such parameters, and, thus, we were unable to directly evaluate whether better embryo quality is associated with a good perinatal outcome after elective single ET, particularly among women 35-37 years of age. In addition, we could not evaluate the potential impact of clinic policies on elective single ET use. A clinician's decision to recommend elective single ET may be affected by the clinic's PRs, an element of elective single ET selection criteria that we did not assess. Finally, NASS validation results indicate that infertility diagnosis has a relatively high discrepancy rate (approximately 18% in 2010) (13) , with about half of the discrepancies due to report of a single cause of infertility when multiple causes were noted in the medical record.
Although rates of elective single ET increased significantly during the 12-year study period, our findings suggest there may be additional patients who could be considered strong candidates for elective single ET. Continuing to redefine a "successful" ART outcome as a healthy singleton birth, may further motivate clinicians to consider elective single ET for their patients. By investigating factors associated with a good perinatal outcome, we aimed to help identify those patients who may be good candidates for elective single ET but are not included in the "favorable prognosis" group by the current ET guidelines. Our findings support better birth outcomes associated with younger age, day 5 transfer, race/ethnicity (non-Hispanic white), and the absence of uterine factor infertility. However, our results also indicate that the use of elective single ET may be appropriate for women aged 35-37 years, and couples affected by male factor infertility. Consideration of these factors may further continue the downward trend in number of embryos transferred, thereby decreasing the current rate of twin births among patients receiving ART. 26 
